Douglas B. Snyder - Net Worth and Insider Trading

Douglas B. Snyder Net Worth

The estimated net worth of Douglas B. Snyder is at least $14 Million dollars as of 2024-06-21. Douglas B. Snyder is the Chief Legal Officer of GW Pharmaceuticals PLC and owns about 61,848 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $14 Million. Details can be seen in Douglas B. Snyder's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas B. Snyder has not made any transactions after 2021-03-26 and currently still holds the listed stock(s).

Transaction Summary of Douglas B. Snyder

To

Douglas B. Snyder Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas B. Snyder owns 1 companies in total, including GW Pharmaceuticals PLC (GWPH) .

Click here to see the complete history of Douglas B. Snyder’s form 4 insider trades.

Insider Ownership Summary of Douglas B. Snyder

Ticker Comapny Transaction Date Type of Owner
GWPH GW Pharmaceuticals PLC 2021-03-26 Chief Legal Officer

Douglas B. Snyder Latest Holdings Summary

Douglas B. Snyder currently owns a total of 1 stock. Douglas B. Snyder owns 61,848 shares of GW Pharmaceuticals PLC (GWPH) as of March 26, 2021, with a value of $14 Million.

Latest Holdings of Douglas B. Snyder

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GWPH GW Pharmaceuticals PLC 2021-03-26 61,848 218.96 13,542,238

Holding Weightings of Douglas B. Snyder


Douglas B. Snyder Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas B. Snyder has made a total of 10 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in GW Pharmaceuticals PLC is the sale of 8,400 shares on March 26, 2021, which brought Douglas B. Snyder around $152,208.

Insider Trading History of Douglas B. Snyder

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas B. Snyder Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Douglas B. Snyder Ownership Network

Ownership Network List of Douglas B. Snyder

No Data

Ownership Network Relation of Douglas B. Snyder

Insider Network Chart

Douglas B. Snyder Owned Company Details

What does GW Pharmaceuticals PLC do?

Who are the key executives at GW Pharmaceuticals PLC?

Douglas B. Snyder is the Chief Legal Officer of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Medical Officer Volker Knappertz , Secretary Adam D. George , and director & Executive Chairman Guy Geoffrey W Dr .

GW Pharmaceuticals PLC (GWPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GW Pharmaceuticals PLC Insider Transactions

No Available Data

Douglas B. Snyder Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas B. Snyder. You might contact Douglas B. Snyder via mailing address: Sovereign House, Vision Park, Histon Cambridge X0 Cb249bz.

Discussions on Douglas B. Snyder

No discussions yet.